{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:55:22Z","timestamp":1792166122283,"version":"4.4.0"},"reference-count":127,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01007","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T04:28:10Z","timestamp":1557894490000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":98,"title":["The Challenges and Promise of Complement Therapeutics for Ocular Diseases"],"prefix":"10.3389","volume":"10","author":[{"given":"Dong Ho","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kip M.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Lambris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/07853890600946724","article-title":"Age-related macular degeneration\u2013emerging pathogenetic and therapeutic concepts","volume":"38","author":"Gehrs","year":"2006","journal-title":"Ann Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health."},{"key":"B3","doi-asserted-by":"publisher","first-page":"802","DOI":"10.2174\/156652410793937813","article-title":"The retinal pigment epithelium in health and disease","volume":"10","author":"Sparrow","year":"2010","journal-title":"Curr Mol Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1152\/physiol.00038.2009","article-title":"Phagocytosis of retinal rod and cone photoreceptors","volume":"25","author":"Kevany","year":"2010","journal-title":"Physiology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ophtha.2011.09.027","article-title":"Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis","volume":"119","author":"Rudnicka","year":"2012","journal-title":"Ophthalmology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/archopht.122.4.564","article-title":"Prevalence of age-related macular degeneration in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch Ophthalmol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2415-10-31","article-title":"Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis","volume":"10","author":"Chakravarthy","year":"2010","journal-title":"BMC Ophthalmol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.ophtha.2003.11.010","article-title":"Risk factors for incident age-related macular degeneration: pooled findings from 3 continents","volume":"111","author":"Tomany","year":"2004","journal-title":"Ophthalmology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ophtha.2004.10.047","article-title":"Age-Related Eye Disease Study Research Group. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19","volume":"112","author":"Clemons","year":"2005","journal-title":"Ophthalmology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/bjophthalmol-2012-302281","article-title":"Is sunlight exposure a risk factor for age-related macular degeneration? A systematic review and meta-analysis","volume":"97","author":"Sui","year":"2013","journal-title":"Br J Ophthalmol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1167\/iovs.08-3064","article-title":"Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables","volume":"50","author":"Seddon","year":"2009","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"582842","DOI":"10.1155\/2014\/582842","article-title":"Age-related macular degeneration: insights into inflammatory genes","volume":"2014","author":"Cascella","year":"2014","journal-title":"J Ophthalmol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"348092","DOI":"10.1155\/2013\/348092","article-title":"The role of the immune response in age-related macular degeneration","volume":"2013","author":"Whitcup","year":"2013","journal-title":"Int J Inflamm."},{"key":"B15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","article-title":"The role of complement in inflammatory diseases from behind the scenes into the spotlight","volume":"171","author":"Markiewski","year":"2007","journal-title":"Am J Pathol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.preteyeres.2009.11.003","article-title":"The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited","volume":"29","author":"Anderson","year":"2010","journal-title":"Prog Retin Eye Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/j.1582-4934.2008.00350.x","article-title":"The alternative complement pathway revisited","volume":"12","author":"Harboe","year":"2008","journal-title":"J Cell Mol Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1126\/science.1195821","article-title":"Structures of C3b in complex with factors B and D give insight into complement convertase formation","volume":"330","author":"Forneris","year":"2010","journal-title":"Science."},{"key":"B22","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1182\/blood.V76.12.2572.2572","article-title":"Regulatory control of the terminal complement proteins at the surface of human endothelial cells: neutralization of a C5b-9 inhibitor by antibody to CD59","volume":"76","author":"Hamilton","year":"1990","journal-title":"Blood."},{"key":"B23","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.4049\/jimmunol.144.9.3478","article-title":"The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9","volume":"144","author":"Rollins","year":"1990","journal-title":"J Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0002-9394(02)01624-0","article-title":"A role for local inflammation in the formation of drusen in the aging eye","volume":"134","author":"Anderson","year":"2002","journal-title":"Am J Ophthalmol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1350-9462(01)00010-6","article-title":"An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration","volume":"20","author":"Hageman","year":"2001","journal-title":"Prog Retin Eye Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"Edwards","year":"2005","journal-title":"Science."},{"key":"B27","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B28","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science."},{"key":"B29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science."},{"key":"B30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/ije\/dyr204","article-title":"Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype","volume":"41","author":"Sofat","year":"2012","journal-title":"Int J Epidemiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/ng.976","article-title":"A rare penetrant mutation in CFH confers high risk of age-related macular degeneration","volume":"43","author":"Raychaudhuri","year":"2011","journal-title":"Nat Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.1093\/hmg\/ddu226","article-title":"Whole-exome sequencing identifies rare, functional CFH variants in families with macular degeneration","volume":"23","author":"Yu","year":"2014","journal-title":"Hum Mol Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/jamaophthalmol.2015.0814","article-title":"Phenotypic Characterization of Complement Factor H R1210C Rare Genetic Variant in Age-Related Macular Degeneration","volume":"133","author":"Ferrara","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1080\/07853890601097030","article-title":"Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: Characterization, ethnic distribution and evolutionary implications","volume":"38","author":"Hageman","year":"2006","journal-title":"Ann Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/ng1890","article-title":"A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration","volume":"38","author":"Hughes","year":"2006","journal-title":"Nat Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1093\/hmg\/ddq399","article-title":"An imbalance of human complement regulatory proteins CFHR1, CFHR3, and factor H influences risk for age-related macular degeneration (AMD)","volume":"19","author":"Fritsche","year":"2010","journal-title":"Hum Mol Genet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/ng2131","article-title":"Variation in complement factor 3 is associated with risk of age-related macular degeneration","volume":"39","author":"Maller","year":"2007","journal-title":"Nat Genet."},{"key":"B38","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1056\/NEJMoa072618","article-title":"Complement C3 variant and the risk of age-related macular degeneration","volume":"357","author":"Yates","year":"2007","journal-title":"N Engl J Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"8761","DOI":"10.1073\/pnas.1019338108","article-title":"Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk","volume":"108","author":"Heurich","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B40","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/ni.1755","article-title":"Structure of complement fragment C3b-factor H and implications for host protection by complement regulators","volume":"10","author":"Wu","year":"2009","journal-title":"Nat Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/ng.2741","article-title":"Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration","volume":"45","author":"Seddon","year":"2013","journal-title":"Nat Genet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ng1750","article-title":"Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration","volume":"38","author":"Gold","year":"2006","journal-title":"Nat Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ng1873","article-title":"Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration","volume":"38","author":"Maller","year":"2006","journal-title":"Nat Genet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1073\/pnas.0812584106","article-title":"Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B","volume":"106","author":"Montes","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B45","doi-asserted-by":"publisher","first-page":"8828","DOI":"10.1167\/iovs.11-7933","article-title":"Complement factor D in age-related macular degeneration","volume":"52","author":"Stanton","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/ejhg.2008.140","article-title":"Variation near complement factor I is associated with risk of advanced AMD","volume":"17","author":"Fagerness","year":"2009","journal-title":"Eur J Hum Genet."},{"key":"B47","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/ng.2640","article-title":"A functional variant in the CFI gene confers a high risk of age-related macular degeneration","volume":"45","author":"van de Ven","year":"2013","journal-title":"Nat Genet."},{"key":"B48","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1167\/iovs.11-8425","article-title":"C9-R95X polymorphism in patients with neovascular age-related macular degeneration","volume":"53","author":"Nishiguchi","year":"2012","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B49","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00346588","article-title":"Sequence polymorphism of human complement factor H","volume":"27","author":"Day","year":"1988","journal-title":"Immunogenetics."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.15252\/embj.201593673","article-title":"Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode","volume":"35","author":"Forneris","year":"2016","journal-title":"EMBO J."},{"key":"B51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00281-017-0649-6","article-title":"The eye as a complement dysregulation hotspot","volume":"40","author":"Clark","year":"2018","journal-title":"Semin Immunopathol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1016\/j.ajpath.2014.07.017","article-title":"The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning","volume":"184","author":"Mullins","year":"2014","journal-title":"Am J Pathol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2014.11.005","article-title":"Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy","volume":"45","author":"Whitmore","year":"2015","journal-title":"Prog Retin Eye Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.1167\/iovs.15-17009","article-title":"Assessment of proteins associated with complement activation and inflammation in maculae of human donors homozygous risk at chromosome 1 CFH-to-F13B.","volume":"56","author":"Keenan","year":"2015","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1042\/BST0381342","article-title":"Complement factor H and age-related macular degeneration: the role of glycosaminoglycan recognition in disease pathology","volume":"38","author":"Clark","year":"2010","journal-title":"Biochem Soc Trans."},{"key":"B56","doi-asserted-by":"publisher","first-page":"18960","DOI":"10.1074\/jbc.M609636200","article-title":"Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism","volume":"282","author":"Herbert","year":"2007","journal-title":"J Biol Chem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.4049\/jimmunol.178.6.3831","article-title":"Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein","volume":"178","author":"Laine","year":"2007","journal-title":"J Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"10894","DOI":"10.1074\/jbc.M610256200","article-title":"The factor H variant associated with age-related macular degeneration (His-384) and the non-disease-associated form bind differentially to C-reactive protein, fibromodulin, DNA, and necrotic cells","volume":"282","author":"Sjoberg","year":"2007","journal-title":"J Biol Chem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"30192","DOI":"10.1074\/jbc.M110.103986","article-title":"Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina","volume":"285","author":"Clark","year":"2010","journal-title":"J Biol Chem."},{"key":"B60","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fimmu.2013.00412","article-title":"The proteoglycan glycomatrix: a sugar microenvironment essential for complement regulation","volume":"4","author":"Clark","year":"2013","journal-title":"Front Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.4049\/jimmunol.1201751","article-title":"Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions","volume":"190","author":"Clark","year":"2013","journal-title":"J Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1159\/000356513","article-title":"The role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H?","volume":"6","author":"Langford-Smith","year":"2014","journal-title":"J Innate Immun."},{"key":"B63","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fimmu.2015.00025","article-title":"Complementing the sugar code: role of GAGs and sialic acid in complement regulation","volume":"6","author":"Langford-Smith","year":"2015","journal-title":"Front Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"E3040","DOI":"10.1073\/pnas.1424391112","article-title":"Regulation of age-related macular degeneration-like pathology by complement factor H","volume":"112","author":"Toomey","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B65","doi-asserted-by":"publisher","first-page":"19528","DOI":"10.1074\/jbc.M112.364471","article-title":"Factor H-related protein 4 activates complement by serving as a platform for the assembly of alternative pathway C3 convertase via its interaction with C3b protein","volume":"287","author":"Hebecker","year":"2012","journal-title":"J Biol Chem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/imr.12500","article-title":"Complement component C3 - The \u201cSwiss Army Knife\u201d of innate immunity and host defense","volume":"274","author":"Ricklin","year":"2016","journal-title":"Immunol Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/hmg\/ddp472","article-title":"Genetic control of the alternative pathway of complement in humans and age-related macular degeneration","volume":"19","author":"Hecker","year":"2010","journal-title":"Hum Mol Genet."},{"key":"B68","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000432401","article-title":"Age-related macular degeneration: a complementopathy?","volume":"54","author":"Kijlstra","year":"2015","journal-title":"Ophthalmic Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e2593","DOI":"10.1371\/journal.pone.0002593","article-title":"Systemic complement activation in age-related macular degeneration","volume":"3","author":"Scholl","year":"2008","journal-title":"PLoS ONE."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aab1482","article-title":"Inhibition of the alternative complement pathway preserves photoreceptors after retinal injury","author":"Sweigard","year":"","journal-title":"Sci Transl Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/pro.5560050401","article-title":"Complement factor D, a novel serine protease","volume":"5","author":"Volanakis","year":"1996","journal-title":"Protein Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1006\/geno.1994.1585","article-title":"The organization of the human complement factor I gene (IF): a member of the serine protease gene family","volume":"24","author":"Vyse","year":"1994","journal-title":"Genomics."},{"key":"B73","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1042\/bj2420849","article-title":"Characterization of primary amino acid sequence of human complement control protein factor I from an analysis of cDNA clones","volume":"242","author":"Catterall","year":"1987","journal-title":"Biochem J."},{"key":"B74","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nsmb.3427","article-title":"Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses","volume":"24","author":"Xue","year":"2017","journal-title":"Nat Struct Mol Biol."},{"key":"B75","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.4049\/jimmunol.127.6.2386","article-title":"The role of C9 in complement-mediated killing of Neisseria","volume":"127","author":"Harriman","year":"1981","journal-title":"J Immunol."},{"key":"B76","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1084\/jem.156.1.268","article-title":"Molecular organization of C9 within the mem$$brane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly","volume":"156","author":"Podack","year":"1982","journal-title":"J Exp Med."},{"key":"B77","first-page":"1","article-title":"ASaP Study Group. Complement C3 inhibitor POT-4: clinical safety of intravitreal administration","volume":"50","author":"Kaushal","year":"2009","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/IAE.0b013e3182979ddd","article-title":"A phase ia dose-escalation study of the anti-factor D monoclonal antibody fragment FCFD4514S in patients with geographic atrophy","volume":"34","author":"Do","year":"2014","journal-title":"Retina."},{"key":"B79","doi-asserted-by":"publisher","first-page":"aaf1443","DOI":"10.1126\/scitranslmed.aaf1443","article-title":"Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration","volume":"9","author":"Yaspan","year":"2017","journal-title":"Sci Transl Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","article-title":"Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: chroma and spectri phase 3 randomized clinical trials","volume":"136","author":"Holz","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ophtha.2013.09.044","article-title":"Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study","volume":"121","author":"Yehoshua","year":"2014","journal-title":"Ophthalmology."},{"key":"B82","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3928\/23258160-20131217-01","article-title":"Change in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degeneration","volume":"45","author":"Garcia Filho","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina."},{"key":"B83","first-page":"1","article-title":"Ophthotech Study Group. Targeting Complement Factor 5 in Combination with Vascular Endothelial Growth Factor (VEGF) Inhibition for Neovascular Age Related Macular Degeneration (AMD): results of a phase 1 study","volume":"51","author":"Cousins","year":"2010","journal-title":"Invest Ophthalmol Visual Sci."},{"key":"B84","unstructured":"Ophthotech Announces Results from Phase 2a Safety Trial of Zimura\u00ae in Combination with Lucentis\u00ae in Wet Age-Related Macular Degeneration2018"},{"key":"B85","first-page":"273","article-title":"Compstatin: a complement inhibitor on its way to clinical application","volume":"632","author":"Ricklin","year":"2008","journal-title":"Adv Exp Med Biol."},{"key":"B86","doi-asserted-by":"crossref","first-page":"884","DOI":"10.4049\/jimmunol.157.2.884","article-title":"Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library","volume":"157","author":"Sahu","year":"1996","journal-title":"J Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/eci.12419","article-title":"Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention","volume":"45","author":"Mastellos","year":"2015","journal-title":"Eur J Clin Invest."},{"key":"B88","unstructured":"28005670Evaluation of AL-78898A in Exudative Age-Related Macular Degeneration2013"},{"key":"B89","unstructured":"Study of APL-2 Therapy in Patients Geographic Atrophy.2017"},{"key":"B90","unstructured":"FILLY - Phase 2 Study of APL-2 in Geographic Atrophy2018"},{"key":"B91","doi-asserted-by":"publisher","first-page":"16229","DOI":"10.1074\/jbc.M110.204701","article-title":"Polyethylene glycol (PEG)-induced mouse model of choroidal neovascularization","volume":"286","author":"Lyzogubov","year":"2011","journal-title":"J Biol Chem."},{"key":"B92","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1440-1827.2011.02695.x","article-title":"Macrophage polarization in the maculae of age-related macular degeneration: a pilot study","volume":"61","author":"Cao","year":"2011","journal-title":"Pathol Int."},{"key":"B93","unstructured":"APL-2 Geogrphaic Atrophy Preliminary 18-month Results2018"},{"key":"B94","unstructured":"Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)2018"},{"key":"B95","unstructured":"APL-2 in Neovascular AMD2018"},{"key":"B96","unstructured":"Amyndas' Priority Clinical Programs2019"},{"key":"B97","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1600-065X.2008.00641.x","article-title":"The spectrum of complement alternative pathway-mediated diseases","volume":"223","author":"Holers","year":"2008","journal-title":"Immunol Rev."},{"key":"B98","doi-asserted-by":"publisher","first-page":"12886","DOI":"10.1074\/jbc.M112.345082","article-title":"Inhibiting alternative pathway complement activation by targeting the factor D exosite","volume":"287","author":"Katschke","year":"2012","journal-title":"J Biol Chem."},{"key":"B99","unstructured":"A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration2018"},{"key":"B100","unstructured":"A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration2018"},{"key":"B101","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/S0161-6420(99)00509-6","article-title":"The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration","volume":"106","author":"Sunness","year":"1999","journal-title":"Ophthalmology."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.3389\/fimmu.2017.01778","article-title":"Bruch's membrane compartmentalizes complement regulation in the eye with implications for therapeutic design in age-related macular degeneration","volume":"8","author":"Clark","year":"2017","journal-title":"Front Immunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000484257","article-title":"Kallikrein Cleaves C3 and activates complement","volume":"10","author":"Irmscher","year":"2018","journal-title":"J Innate Immun."},{"key":"B104","unstructured":"CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA)2017"},{"key":"B105","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.it.2017.03.003","article-title":"Complement C3-targeted therapy: replacing long-held assertions with evidence-based discovery","volume":"38","author":"Mastellos","year":"2017","journal-title":"Trends Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1053\/j.seminhematol.2018.02.002","article-title":"Expanding complement therapeutics for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"55","author":"Mastellos","year":"2018","journal-title":"Semin Hematol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol."},{"key":"B108","unstructured":"Complement Inhibition With Eculizumab for the Treatment of Non-Exudative Macular Degeneration (AMD)2017"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N Engl J Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"E1445","DOI":"10.1002\/humu.21256","article-title":"Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome","volume":"31","author":"Maga","year":"2010","journal-title":"Hum Mutat."},{"key":"B111","unstructured":"Alexion Research and Development: Pipeline2018"},{"key":"B112","unstructured":"Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)2016"},{"key":"B113","unstructured":"Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)2016"},{"key":"B114","unstructured":"Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD)2016"},{"key":"B115","unstructured":"A Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration2017"},{"key":"B116","unstructured":"Zimura in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration2018"},{"key":"B117","unstructured":"ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)2018"},{"key":"B118","unstructured":"ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)2018"},{"key":"B119","unstructured":"Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)2018"},{"key":"B120","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1096\/fj.14-251041","article-title":"The alternative complement pathway regulates pathological angiogenesis in the retina","volume":"28","author":"Sweigard","year":"2014","journal-title":"FASEB J."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1096\/fj.15-280834","article-title":"The alternative complement pathway aids in vascular regression during the early stages of a murine model of proliferative retinopathy","volume":"30","author":"Kim","year":"2016","journal-title":"FASEB J."},{"key":"B122","doi-asserted-by":"publisher","first-page":"e19078","DOI":"10.1371\/journal.pone.0019078","article-title":"A non membrane-targeted human soluble CD59 attenuates choroidal neovascularization in a model of age related macular degeneration","volume":"6","author":"Cashman","year":"2011","journal-title":"PLoS ONE."},{"key":"B123","unstructured":"Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD592017"},{"key":"B124","unstructured":"Luxturna2018"},{"key":"B125","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.smim.2016.06.001","article-title":"New milestones ahead in complement-targeted therapy","volume":"28","author":"Ricklin","year":"2016","journal-title":"Semin Immunol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-1-4419-5635-4_9","article-title":"Suppression of drusen formation by compstatin, a peptide inhibitor of complement C3 activation, on cynomolgus monkey with early-onset macular degeneration","volume":"703","author":"Chi","year":"2010","journal-title":"Adv Exp Med Biol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.it.2012.06.001","article-title":"The complotype: dictating risk for inflammation and infection","volume":"33","author":"Harris","year":"2012","journal-title":"Trends Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01007\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T15:47:15Z","timestamp":1694879235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01007\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":127,"alternative-id":["10.3389\/fimmu.2019.01007"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01007","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,15]]},"article-number":"1007"}}